KALAMAZOO, Mich., Dec. 6 /PRNewswire-FirstCall/ -- Stryker announced today that the Board of Directors has declared a year-end cash dividend of twenty-two cents per share, an increase of 100% over the eleven cent dividend declared in December 2005. The dividend is payable January 31, 2007 to shareholders of record at the close of business on December 29, 2006.
“This increased dividend reflects the Company’s strong cash flow generation capability and allows us to return increased value to shareholders, while maintaining our ability to invest significantly in research and development and make strategic acquisitions. Our commitment to our 20% earnings growth goal remains unchanged,” commented Stephen P. MacMillan, President and Chief Executive Officer.
Stryker Corporation is one of the world’s leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company’s products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States.
Stryker Corporation
CONTACT: Dean H. Bergy, Vice President and Chief Financial Officer ofStryker Corporation, +1-269-385-2600
Web site: http://www.stryker.com/
